Speaker illustration

Doctor Anna Slattman

Skane University Hospital, Lund (Sweden)

Pacemaker implantation due to cardiac conduction disease in patients with subsequent cardiac sarcoidosis may be a marker of early disease and is associated with adverse 5-year clinical outcome

Event: ESC Congress 2022

Topic: Atrioventricular (AV) Block

Session: Evaluation and treatment of conduction disease in 2022


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb